Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Free Cash Flow (2023 - 2025)

Historic Free Cash Flow for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$60.6 million.

  • Nuvation Bio's Free Cash Flow fell 9416.0% to -$60.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$198.0 million, marking a year-over-year decrease of 9932.85%. This contributed to the annual value of -$130.6 million for FY2024, which is 9183.02% down from last year.
  • As of Q3 2025, Nuvation Bio's Free Cash Flow stood at -$60.6 million, which was down 9416.0% from -$48.4 million recorded in Q2 2025.
  • Nuvation Bio's Free Cash Flow's 5-year high stood at -$15.0 million during Q4 2023, with a 5-year trough of -$60.6 million in Q3 2025.
  • In the last 3 years, Nuvation Bio's Free Cash Flow had a median value of -$31.2 million in 2024 and averaged -$31.8 million.
  • The largest annual percentage gain for Nuvation Bio's Free Cash Flow in the last 5 years was 1867.96% (2024), contrasted with its biggest fall of 20773.17% (2024).
  • Quarter analysis of 3 years shows Nuvation Bio's Free Cash Flow stood at -$15.0 million in 2023, then plummeted by 207.73% to -$46.3 million in 2024, then tumbled by 31.01% to -$60.6 million in 2025.
  • Its last three reported values are -$60.6 million in Q3 2025, -$48.4 million for Q2 2025, and -$42.7 million during Q1 2025.